The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
The Human Cytomegalovirus UL11 Protein Interacts with the Receptor Tyrosine Phosphatase CD45, Resulting in Functional Paralysis of T Cells
Open accessAbstract
Human cytomegalovirus (CMV) exerts diverse and complex effects on the immune system, not all of which have been attributed to viral genes. Acute CMV infection results in transient restrictions in T cell proliferative ability, which can impair the control of the virus and increase the risk of secondary infections in patients with weakened or immature immune systems. In a search for new immunomodulatory proteins, we investigated the UL11 protein, a member of the CMV RL11 family. This protein family is defined by the RL11 domain, which has homology to immunoglobulin domains and adenoviral immunomodulatory proteins. We show that pUL11 is expressed on the cell surface and induces intercellular interactions with leukocytes. This was demonstrated to be due to the interaction of pUL11 with the receptor tyrosine phosphatase CD45, identified by mass spectrometry analysis of pUL11-associated proteins. CD45 expression is sufficient to mediate the interaction with pUL11 and is required for pUL11 binding to T cells, indicating that pUL11 is a specific CD45 ligand. CD45 has a pivotal function regulating T cell signaling thresholds; in its absence, the Src family kinase Lck is inactive and signaling through the T cell receptor (TCR) is therefore shut off. In the presence of pUL11, several CD45-mediated functions were inhibited. The induction of tyrosine phosphorylation of multiple signaling proteins upon TCR stimulation was reduced and T cell proliferation was impaired. We therefore conclude that pUL11 has immunosuppressive properties, and that disruption of T cell function via inhibition of CD45 is a previously unknown immunomodulatory strategy of CMV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 pUL11 treatment results in reduced T cell signaling and proliferation. (A) Immunoblot with the 4G10 phosphotyrosine-specific antibody (upper panel) or anti-actin (lower panel) of lysates from Jurkat cells that were either left untreated or were pretreated with UL11Fc or the Fc domain (2.5 µg) for 30 min prior to stimulation with a Jurkat TCR-specific antibody (C305) for the indicated times. (B) Primary T cells were either left untreated (medium) or were incubated with the CD3-specific antibody OKT3 or with phytohaemagglutinin (PHA) together with BSA, UL11Fc or the Fc domain (2 µg) for 3 days. Following incubation for 16 h with 3[H]-thymidine radionucleotide incorporation was measured. All samples were handled in triplicate. Representative data from one of three experiments are shown.](https://figures.cochat.ai/paper-figures/b98294d6176f47ddaa6e6710bb2340af/the-human-cytomegalovirus-ul11-protein-interacts-with-the-receptor-tyrosine-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“pUL11 binding reduced tyrosine phosphorylation, leading to inhibition of T cell proliferation (66).”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Varki, A. P., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Etzler, M. E. (1999) · Cited by 2,384
Smith-Garvin, J. E., Koretzky, G. A., & Jordan, M. S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132706 · Cited by 2,144
Straus, D. (1992) · Cell · doi:10.1016/0092-8674(92)90428-f · Cited by 1,034
CD45: A Critical Regulator of Signaling Thresholds in Immune Cells
Hermiston, M. L., Xu, Z., & Weiss, A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.140946 · Cited by 946
Recognition of a virus-encoded ligand by a natural killer cell activation receptor
Smith, H. R. C., Heusel, J. W., Mehta, I. K., Kim, S., Dorner, B. G., Naidenko, O. V., Iizuka, K., Furukawa, H., Beckman, D. L., Pingel, J. T., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092258599 · Cited by 767
The Leukocyte Common Antigen Family
Thomas, M. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.002011 · Cited by 730
High-titer packaging cells producing recombinant retroviruses resistant to human serum
Cosset, F. L., Takeuchi, Y., Battini, J. L., Weiss, R. A., & Collins, M. K. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.7430-7436.1995 · Cited by 661
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains
Cha, T. A., Tom, E., Kemble, G. W., Duke, G. M., Mocarski, E. S., & Spaete, R. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.78-83.1996 · Cited by 611
Genetic content of wild-type human cytomegalovirus
Dolan, A., Cunningham, C., Hector, R. D., Hassan-Walker, A. F., Lee, L., Addison, C., Dargan, D. J., McGeoch, D. J., Gatherer, D., Emery, V. C., et al. (2004) · Journal of General Virology · doi:10.1099/vir.0.79888-0 · Cited by 557
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)
Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V., & Pestka, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1695 · Cited by 519
Cited by
Quantitative Temporal Viromics: An Approach to Investigate Host-Pathogen Interaction
Weekes, M. P., Tomasec, P., Huttlin, E. L., Fielding, C. A., Nusinow, D., Stanton, R. J., Wang, E. C. Y., Aicheler, R., Murrell, I., Wilkinson, G. W. G., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.028 · Cited by 431
Self-citationCD45 in human physiology and clinical medicine
Rheinländer, A., Schraven, B., & Bommhardt, U. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.009 · Cited by 294
Protein tyrosine phosphatase receptor type C (PTPRC or CD45)
Al Barashdi, M. A., Ali, A., McMullin, M. F., & Mills, K. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206927 · Cited by 242
Martinez-Martin, N., Ramani, S. R., Hackney, J. A., Tom, I., Wranik, B. J., Chan, M., Wu, J., Paluch, M. T., Takeda, K., Hass, P. E., et al. (2017) · Nature Communications · doi:10.1038/ncomms16150 · Cited by 242
Sijmons, S., Thys, K., Mbong Ngwese, M., Van Damme, E., Dvorak, J., Van Loock, M., Li, G., Tachezy, R., Busson, L., Aerssens, J., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00578-15 · Cited by 180
Metadata
- Authors
- Gabaev, I., Steinbrück, L., Pokoyski, C., Pich, A., Stanton, R. J., Schwinzer, R., Schulz, T. F., Jacobs, R., Messerle, M., & Kay-Fedorov, P. C.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Cardiff University (GB)
- Corresponding author
- Messerle, Martin
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-12-08
- Volume
- 7
- Issue
- 12
- Pages
- e1002432
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3234252
- OpenAlex
- W2001518190
- Cited by
- 58
- References
- 97
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 6 · 2017: 1 · 2016: 5 · 2015: 5 · 2014: 11 · 2013: 4
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft
- Medizinischen Hochschule Hannover
- Topics
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- human cytomegalovirus, CD45, receptor tyrosine phosphatase, T cell suppression, T cell receptor signaling, Lck kinase, T cell proliferation, viral immunomodulation, tyrosine phosphorylation
- MeSH terms
- Cell Line, Cell Separation, Cytomegalovirus Infections, Cytomegalovirus, Flow Cytometry, Humans, Mass Spectrometry, T-Lymphocytes, Transfection, Viral Proteins, Leukocyte Common Antigens, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.